138 filings
Page 3 of 7
8-K
vf198va rjq
17 Oct 22
Regulation FD Disclosure
6:07am
8-K
od6 ipggj
10 Aug 22
Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update
4:38pm
8-K
eyy5j1
8 Jul 22
Submission of Matters to a Vote of Security Holders
4:00pm
DEFA14A
vxgox4k1
2 May 22
Additional proxy soliciting materials
5:17pm
PRE 14A
8ustxp2i4 0g6lpvnp
21 Apr 22
Preliminary proxy
9:00pm
8-K
4gtmq3
24 Mar 22
Index to Consolidated Financial Statements
7:42am
S-8
0a88it4ks7ua
24 Mar 22
Registration of securities for employees
7:36am
8-K
witood2x83o
16 Feb 22
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer
7:37am
EFFECT
59xhuwsari09r p8t7
3 Feb 22
Notice of effectiveness
12:15am
CORRESP
u7lb sp9jx
31 Jan 22
Correspondence with SEC
12:00am
UPLOAD
1vm6tn1avcqf
19 Nov 21
Letter from SEC
12:00am
8-K
j2n4iv0vc43g6y
12 Nov 21
Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update
7:38am
EFFECT
tqp39539vjv31ausbbsf
8 Nov 21
Notice of effectiveness
12:15am
CORRESP
4im9irz
4 Nov 21
Correspondence with SEC
12:00am